Clinical trials
Completed Respiratory Insufficiency trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
188 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 11 |
| 2012 | 9 |
| 2013 | 12 |
| 2014 | 12 |
| 2015 | 11 |
| 2016 | 12 |
| 2017 | 8 |
| 2018 | 12 |
| 2019 | 6 |
| 2020 | 26 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 188 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wake Forest University Health Sciences | 6 |
| Massachusetts General Hospital | 5 |
| Children's Hospital Medical Center, Cincinnati | 4 |
| Duke University | 4 |
| Johns Hopkins University | 4 |
| McMaster University | 4 |
| Medtronic - MITG | 4 |
| Stanford University | 4 |
| University of Florida | 4 |
| Vanderbilt University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Insufficiency | 188 |
| COVID-19 | 20 |
| Respiratory Distress Syndrome | 17 |
| Critical Illness | 13 |
| Sepsis | 9 |
| Pneumonia | 8 |
| Heart Failure | 7 |
| Acute Lung Injury | 6 |
| Pain | 5 |
| Postoperative Pain | 5 |
Trials
Showing 1 to 25 of 188. Each trial links to its page on Pharma Observatory.
88 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.